Xiaojuan Wang

Key Laboratory Of Digital Intelligence Hepatology
Beijing, 102218, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Tertiary lymphoid structures in hepatocellular carcinoma: Prognostic biomarker, immunotherapy predictor, and emerging therapeutic target.

Tertiary lymphoid structures in hepatocellular carcinoma: Prognostic biomarker, immunotherapy predictor, and emerging therapeutic target.

Journal: Cancer letters
Published: March 31, 2026

Spatial multi-omics identifies a NOTCH3-mediated capillary-mCAF crosstalk driving immune exclusion in hepatocellular carcinoma.

Spatial multi-omics identifies a NOTCH3-mediated capillary-mCAF crosstalk driving immune exclusion in hepatocellular carcinoma.

Journal: iMeta
Published: January 29, 2026

Spatial multi omic profiling maps hypoxia-driven pro-fibrotic SPP1+ macrophages underpinning immune escape and TACE resistance in hepatocellular carcinoma.

Spatial multi omic profiling maps hypoxia-driven pro-fibrotic SPP1+ macrophages underpinning immune escape and TACE resistance in hepatocellular carcinoma.

Journal: Experimental hematology & oncology
Published: December 17, 2025

Spatial multi-omics mapping of tumor microanatomy dynamics following radiotherapy combined with targeted-immunotherapy in hepatocellular carcinoma.

Spatial multi-omics mapping of tumor microanatomy dynamics following radiotherapy combined with targeted-immunotherapy in hepatocellular carcinoma.

Journal: Biomarker research
Published: August 11, 2025

Empowering liver cancer diagnosis and treatment with foundation models: technological innovation and clinical practice.

Empowering liver cancer diagnosis and treatment with foundation models: technological innovation and clinical practice.

Journal: Clinical and experimental medicine
Published: July 30, 2025

FGF1-FGFR2 axis regulated by nuclear receptor RORγ represents an effective strategy in intrahepatic cholangiocarcinoma.

FGF1-FGFR2 axis regulated by nuclear receptor RORγ represents an effective strategy in intrahepatic cholangiocarcinoma.

Journal: Cell death discovery
Published: July 26, 2025

Precision medicine in liver transplantation for hepatocellular carcinoma: applications and prospects of third-generation sequencing technology.

Precision medicine in liver transplantation for hepatocellular carcinoma: applications and prospects of third-generation sequencing technology.

Journal: Journal of cancer research and clinical oncology
Published: July 18, 2025

Comprehensive pan-cancer analysis of RPRD1B as a promising diagnostic and prognostic biomarker.

Comprehensive pan-cancer analysis of RPRD1B as a promising diagnostic and prognostic biomarker.

Journal: Discover oncology
Published: June 17, 2025

Machine perfusion prevents early tumor recurrence in liver transplantation for hepatocellular carcinoma: a multicenter retrospective cohort study.

Machine perfusion prevents early tumor recurrence in liver transplantation for hepatocellular carcinoma: a multicenter retrospective cohort study.

Journal: Cancer letters
Published: June 10, 2025

Bibliometric analysis and global trends in Sphincter of Oddi Dysfunction.

Bibliometric analysis and global trends in Sphincter of Oddi Dysfunction.

Journal: International journal of surgery (London, England)
Published: May 10, 2025

Roles of Hypoxia and Mitochondrial Energy Metabolism Related Genes in Predicting the Prognosis of Liver Hepatocellular Carcinoma.

Roles of Hypoxia and Mitochondrial Energy Metabolism Related Genes in Predicting the Prognosis of Liver Hepatocellular Carcinoma.

Journal: Digestive diseases and sciences
Published: April 22, 2025

A generative vision-language model for holistic pathological assessment using preoperative imaging in hepatocellular carcinoma.

A generative vision-language model for holistic pathological assessment using preoperative imaging in hepatocellular carcinoma.

Journal: EBioMedicine
Published: February 17, 2025
Showing 1-12 of 18

Last Updated: 09/26/2026